1.北京中医药大学东直门医院,北京市东城区海运仓5号,100700
2.中国人民解放军总医院第五医学中心
3.北京中医药大学中医学院
4.北京中医药大学国家中医体质与治未病研究院
WRL7905@163.com
收稿:2023-06-27,
修回:2023-09-15,
纸质出版:2023-12-02
移动端阅览
余思邈,丁霞,李萍等.慢性乙型肝炎恶性转化过程证候、证素演变规律的临床研究[J].中医杂志,2023,64(23):2427-2434.
YU Simiao,DING Xia,LI Ping,et al.Evolutionary Law of Syndrome and Syndrome Elements during the Malignant Transformation of Chronic Hepatitis B[J].Journal of Traditional Chinese Medicine,2023,64(23):2427-2434.
余思邈,丁霞,李萍等.慢性乙型肝炎恶性转化过程证候、证素演变规律的临床研究[J].中医杂志,2023,64(23):2427-2434. DOI: 10.13288/j.11-2166/r.2023.23.010.
YU Simiao,DING Xia,LI Ping,et al.Evolutionary Law of Syndrome and Syndrome Elements during the Malignant Transformation of Chronic Hepatitis B[J].Journal of Traditional Chinese Medicine,2023,64(23):2427-2434. DOI: 10.13288/j.11-2166/r.2023.23.010.
目的
2
明确慢性乙型肝炎(CHB)恶性转化过程中不同阶段的证候演变规律。
方法
2
收集2020年7月1日至2021年6月30日就诊于北京中医药大学东直门医院、解放军总医院第五医学中心门诊及住院的乙型肝炎病毒感染者共671例,其中CHB 120例,乙型肝炎肝硬化(HBLC)340例,乙型肝炎肝硬化伴肝细胞癌前病变(PLHC)64例,乙型肝炎肝硬化伴肝细胞癌(HCC)147例。设计“慢性乙型肝炎恶性转化中医证候临床调查表”,记录患者一般资料、辅助检查结果及中医四诊信息。基于因子分析及K-均值聚类分析对其证候、证素进行判定及统计分析。
结果
2
得到CHB中医证候类型5个,肝硬化(HBLC、PLHC、HCC)中医证候类型6个。其中CHB患者的证候分布主要以肝郁脾虚证(53.33%)、肝胆湿热证(21.67%)为主,证素分布以气滞(27.60%)、热(17.71%)、气虚(17.71%)为主;HBLC阶段证候分布以瘀血阻络证(23.83%)、肝郁脾虚证(22.35%)为主,证素分布以血瘀(19.25%)、湿(17.46%)、气虚(15.01%)为主;PLHC阶段证候分布以瘀血阻络证(29.68%)、肝肾阴虚证(20.31%)为主,证素分布以血瘀(22.12%)、阴虚(15.93%)、气虚(15.04%)为主;HCC阶段证候分布以瘀血阻络证(33.34%)、肝肾阴虚证(19.73%)为主,证素分布以血瘀(24.52%)、阴虚(16.09%)、气虚(15.33%)为主。CHB恶性转化的过程中,呈现出实证(肝胆湿热证、水湿内阻证)占比逐渐减少(21.67%→19.04%),虚证(肝肾阴虚证、脾肾阳虚证)占比逐渐增多(15.83%→31.97%),且实性证素(气滞、热、湿)比例逐渐减少(59.89%→34.48%),虚性证素(气虚、阴虚、阳虚)比例逐渐增加(32.30%→41.00%)。
结论
2
慢性乙型肝炎恶性转化的过程中,存在气滞、热、气虚→血瘀(偏实)、湿、气虚→血瘀(偏虚)、阴虚、气虚的“虚实夹杂、由实转虚”的证候、证素演变趋势。
Objective
2
To clarify the evolutionary laws of syndromes and syndrome elements at different stages during the malignant transformation of chronic hepatitis B (CHB).
Methods
2
A total of 671 patients with hepatitis B virus infection, who were admitted to the outpatient and inpatient departments of Dongzhimen Hospital of Beijing University of Chinese Medicine and The Fifth Medical Center of Chinese PLA General Hospital from July 1st, 2020 to June 30th, 2021, were included, involving 120 cases of CHB, 340 cases of hepatitis B liver cirrhosis (HBLC), 64 cases of precancerous lesions with hepatitis B liver cirrhosis (PLHC), and 147 cases of hepatitis B liver cirrhosis with hepatocellular carcinoma (HCC). A
Survey form of traditional Chinese medicine syndrome during malignant transformation of chronic hepatitis B
was designed, and the general information, auxiliary examination and the four examinations results were collected. Factor analysis and K-means clustering were used to determine and statistically analyze the syndrome and syndrome elements.
Results
2
Five traditional Chinese medicine (TCM) syndrome types were identified in CHB patients, while there were six TCM syndrome types in HBLC, PLHC and HCC stages. Among CHB patients, the main syndromes were liver constraint and spleen deficiency (53.33%) and liver-gallbladder damp-heat (21.67%), and the dominant syndrome elements were
qi
stagnation (27.60%), heat (17.71%) and
qi
deficiency (17.71%). In the HBLC stage, the syndromes were mainly blood stasis obstructing the collaterals (23.83%) and liver constraint and spleen deficiency (22.35%), with dominant syndrome elements being blood stasis (19.25%), dampness (17.46%), and
qi
deficiency (15.01%). For the PLHC stage, the primary syndrome types were blood stasis obstructing the collaterals (29.68%) and liver-kidney
yin
deficiency (20.31%), and the leading syndrome elements were blood stasis (22.12%),
yin
deficiency (15.93%), and
qi
deficiency (15.04%). In the HCC stage, the syndrome was dominated by blood stasis obstructing the collaterals (33.34%) and liver-kidney
yin
deficiency (19.73%), with the main syndrome elements being blood stasis (24.52%),
yin
deficiency (16.09%), and
qi
deficiency (15.33%). During the progression of CHB to malignancy, there was a gradual decrease in excess syndromes including liver-gallbladder damp-heat and water-dampness internal obstruction from 21.67% to 19.04%. In contrast, deficiency syndromes including liver-kidney
yin
deficiency and spleen-kidney
yang
deficiency increased from 15.83% to 31.97%. Additionally, excess syndrome elements including
qi
stagnation, heat and dampness decreased from 59.89% to 34.48%, while deficiency syndrome elements including
qi
deficiency,
yin
deficiency and
yang
deficiency increased from 32.30% to 41.00%.
Conclusion
2
During the malignant transformation of CHB, there exists a progression of syndrome and syndrome elements, shifting from
qi
stagnation, heat and
qi
deficiency to blood stasis (predominantly excess), dampness and
qi
deficiency, and then to blood stasis (predominantly deficiency),
yin
deficiency and
qi
deficiency, characterized by “deficiency-excess complex, and shift from excess to deficiency”.
LIU J , LIANG W , JING W , et al . Countdown to 2030: eliminating hepatitis B disease,China [J]. Bull World Health Organ , 2019 , 97 ( 3 ): 230 - 238 .
TREPO C , CHAN HL , LOK A . Hepatitis B virus infection [J]. Lancet , 2014 , 384 ( 9959 ): 2053 - 2063 .
中华医学会肝病学分会肝癌学组 . 肝细胞癌癌前病变的诊断和治疗多学科专家共识(2020版) [J]. 临床肝胆病杂志 , 2020 , 36 ( 3 ): 514 - 518 .
中国人群肝癌筛查指南制定专家组 , 中国人群肝癌筛查指南制定工作组 . 中国人群肝癌筛查指南(2022,北京) [J]. 临床肝胆病杂志 , 2022 , 38 ( 8 ):1739-1758, 1954 - 1967 .
宁麟 , 孙建光 . 原发性肝癌癌前病变中西医研究进展 [J]. 世界科学技术-中医药现代化 , 2021 , 23 ( 10 ): 3590 - 3598 .
中华中医药学会肝胆病分会 . 病毒性肝炎中医辨证标准(2017年版) [J]. 中西医结合肝病杂志 , 2017 , 27 ( 3 ): 193 - 194 .
中华中医药学会肝胆病专业委员会 , 中国民族医药学会肝病专业委员会 . 慢性乙型肝炎中医诊疗指南(2018年版) [J]. 中西医结合肝病杂志 , 2019 , 29 ( 1 ): 97 - 102 .
中国中西医结合学会消化系统疾病专业委员会 . 肝硬化中西医结合诊疗共识 [J]. 中国中西医结合消化杂志 , 2011 , 19 ( 4 ): 277 - 279 .
中华中医药学会脾胃病分会 . 肝硬化腹水中医诊疗专家共识意见(2017) [J]. 临床肝胆病杂志 , 2017 , 33 ( 9 ): 1621 - 1626 .
国家重大疑难疾病(原发性肝癌)中西医临床协作组 . 原发性肝癌中西医结合诊疗专家共识 [J]. 中医药导报 , 2021 , 27 ( 9 ): 101 - 107 .
2019年肝癌中西医临床协作专家委员会 . 原发性肝癌中西医结合介入诊疗专家共识(试行第一版) [J]. 临床肝胆病杂志 , 2022 , 38 ( 1 ): 70 - 77 .
2019年肝癌中西医临床协作专家委员会 . 原发性肝癌微创消融联合中医诊疗专家共识 [J]. 中华介入放射学电子杂志 , 2021 , 9 ( 1 ): 9 - 19 .
中华医学会感染病学分会 , 中华医学会肝病学分会 . 慢性乙型肝炎防治指南(2019年版) [J]. 中国肝脏病杂志 (电子版), 2019 , 11 ( 4 ): 5 - 27 .
中华医学会肝病学分会 . 肝硬化诊治指南 [J]. 临床肝胆病杂志 , 2019 , 35 ( 11 ): 2408 - 2425 .
中华人民共和国国家卫生健康委员会医政医管局 . 原发性肝癌诊疗规范(2019年版) [J]. 临床肝胆病杂志 , 2020 , 36 ( 2 ): 277 - 292 .
国家中医药管理局华东南中医肝病诊疗中心联盟 . 积聚(肝硬化代偿期)中医诊疗方案 [J]. 中国肝脏病杂志 (电子版), 2022 , 14 ( 2 ): 18 - 26 .
国家技术监督局 . 中医临床诊疗术语:证候部分 [S]. 北京 : 中国标准出版社 , 1997 : 45 - 81 .
全国科学技术名词审定委员会 . 中医药学名词 [M]. 北京 : 科学出版社 , 2005 : 463 .
李灿东 . 中医诊断学 [M]. 4版 . 北京 : 中国中医药出版社 , 2017 : 70 - 80 .
朱文锋 . 证素辨证学 [M]. 北京 : 人民卫生出版社 , 2008 : 88 - 161 .
姚乃礼 . 中医证候鉴别诊断学 [M]. 2版 . 北京 : 人民卫生出版社 , 2002 : 274 - 363 .
郑筱萸 . 中药新药临床研究指导原则(试行) [M]. 2版 . 北京 : 中国医药科技出版社 , 2002 : 143 - 151 .
安澜 , 曾红梅 , 郑荣寿 , 等 . 2015年中国肝癌流行情况分析 [J]. 中华肿瘤杂志 , 2019 , 41 ( 10 ): 721 - 727 .
BRAY F , FERLAY J , SOERJOMATARAM I , et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2018 , 68 ( 6 ): 394 - 424 .
秦丽萍 , 郎庆波 , 翟东霞 , 等 . 2958例乙型肝炎病毒感染者证候分布初探 [J]. 中医杂志 , 2011 , 52 ( 17 ): 1469 - 1471 .
叶永安 , 田德禄 , 蒋健 , 等 . 1003例慢性乙型肝炎(ALT≥2×ULN)患者中医常见症状及证候分布特点研究 [J]. 世界中医药 , 2015 , 10 ( 9 ): 1293 - 1298,1304 .
李力 , 徐懂 , 翁奉武 , 等 . 基于因子分析与聚类分析的572例乙型肝炎后肝硬化中医证候规律研究 [J]. 北京中医药大学学报 , 2021 , 44 ( 12 ): 1108 - 1117 .
李永健 , 方肇勤 , 唐辰龙 , 等 . 2060例原发性肝癌中医证候分布规律的临床流行病学调查研究 [J]. 中国医药学报 , 2003 , 18 ( 3 ): 144 - 146,192 .
0
浏览量
4
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号